Back to search
FDAFDA · Food and drugs·Recall number D-0625-2017

Kalbitor (ecallantide), 10mg/mL, packaged in 3 vials per Carton, Rx Only, Dynax Corp., Burlington, MA. NDC47783-101-01

Published April 12, 2017 · Recall initiated: March 17, 2017

Summary

FDA records drug Class II recall D-0625-2017, published April 12, 2017 and initiated March 17, 2017. Recalling firm: Shire; Status: Terminated; Reported quantity: 3, 536 cartons (3 vials per carton); Lot: Lot #: A1500009, Exp. Jan 31, 2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Glass

What to do

Voluntary: Firm initiated · Letter

Get an email if KALBITOR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
KALBITOR
Manufacturer
Shire
Distributor
Nationwide and Kuwait
Lot
Lot #: A1500009, Exp. Jan 31, 2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Kalbitor (ecallantide), 10mg/mL, packaged in 3 vials per Carton, Rx Only, Dynax Corp., Burlington, MA. NDC47783-101-01 recalled?

Yes. FDA published recall D-0625-2017 on April 12, 2017. Reported hazard: Presence of Particulate Matter: Glass

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: KALBITOR.